Nancy Cheskey
I went for my routine mammogram on August 14, 2023, .....
I went for my routine mammogram on August 14, 2023, .....
COA’s Director of Patient Advocacy and Education and Advocacy Chat host, Rose Gerber, MS, and COA’s Managing Director Nicolas Ferreyros will analyze the current state of COA’s policy priorities, including pharmacy benefit managers, 340B, and prior authorization reform.
COA’s Director of Patient Advocacy and Education and Advocacy Chat host, Rose Gerber, MS, will be joined by Shelley Fuld Nasso, MPP, the CEO of the National Coalition for Cancer Survivorship. Rose and Shelley will discuss the common aspects of cancer survivorship and the latest results from the annual State of Survivorship Survey, which asks patients and survivors for their perspectives on the treatment journey and related factors.
Rose Gerber, MS, Advocacy Chat host and COA’s Director of Patient Advocacy and Education, were joined by Shannon Besselman, RN, BSN, a clinical manager for Northwest Medical Specialties on a discussion of the roles that oncology nurses play in community oncology practices.
COA’s Director of Patient Advocacy and Education and CPAN host, Rose Gerber, MS, and COA’s Director of State and Policy James Lee will lead the April Advocacy Chat, exploring the growing importance of state level advocacy. They will talk about current issues being explored at the state level, like PBM reform, effective ways to establish working relationships with elected officials, and ways you can get involved with advocacy efforts at COA.
April Rozzo, MS, RD, CSO, LD/N, the clinical nutrition manager at Florida Cancer Specialists and Research Institute, met with Rose to talk about the importance of crafting personalized dietary recommendations for patients with cancer and survivors at all stages of the cancer care continuum.
I was diagnosed in January of 2012 with late-stage aggressive .....
The COA Patient Advocacy Network (CPAN) met on Wednesday, February 12, 2025, for a discussion on how the causes of cancer prevention and common-sense cancer policy are fueled by personal experiences.
In 2024, COA’s Patient Advocacy Network (CPAN) provided advocacy, education, and engagement opportunities in multiple ways.
On Wednesday, January 8, 2025, at 12 p.m. ET, COA's Executive Director Ted Okon, Managing Director Nick Ferreyros, and Director of Patient Advocacy and Education Rose Gerber prepared you for a year of advocacy with insight on key cancer policy issues for 2025.